Cargando…

ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients

BACKGROUND: Our objective was to assess the association between intensive care unit (ICU)‐free days and patient outcomes in pediatric prehospital care and to evaluate whether ICU‐free days is a more sensitive outcome measure for emergency medical services research in this population. METHODS: This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hanjin, Wendelberger, Barbara, Gausche‐Hill, Marianne, Wang, Henry E, Hansen, Matthew, Bosson, Nichole, Lewis, Roger J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262607/
https://www.ncbi.nlm.nih.gov/pubmed/34263247
http://dx.doi.org/10.1002/emp2.12479
_version_ 1783719218642944000
author Cho, Hanjin
Wendelberger, Barbara
Gausche‐Hill, Marianne
Wang, Henry E
Hansen, Matthew
Bosson, Nichole
Lewis, Roger J.
author_facet Cho, Hanjin
Wendelberger, Barbara
Gausche‐Hill, Marianne
Wang, Henry E
Hansen, Matthew
Bosson, Nichole
Lewis, Roger J.
author_sort Cho, Hanjin
collection PubMed
description BACKGROUND: Our objective was to assess the association between intensive care unit (ICU)‐free days and patient outcomes in pediatric prehospital care and to evaluate whether ICU‐free days is a more sensitive outcome measure for emergency medical services research in this population. METHODS: This study used data from a previous pediatric prehospital trial. The original study enrolled patients ≤12 years of age and compared bag‐valve‐mask‐ventilation (BVM) versus endotracheal intubation (ETI) during prehospital resuscitation. For the current study, we defined ICU‐free days as 30 minus the number of days in the ICU (range, 0–30 days) and assigned 0 ICU‐free days for death within 30 days. We compared ICU‐free days between the original study treatment groups (BVM vs ETI) and with the original trial outcomes of survival to hospital discharge and Pediatric Cerebral Performance Category (PCPC). RESULTS: Median ICU‐free days for the BVM group (n = 404) versus ETI group (n = 416) was not statistically different: 0 ICU‐free days (interquartile range, 0–10) versus 0 (0–0), P = 0.219. Median ICU‐free days were greater for BVM group in 3 subgroups: foreign body aspiration 30 (0–30) versus 0 (0–21), P = 0.028; child maltreatment 0 (0–14.2) versus 0 (0‐0), P = 0.004; and respiratory arrest 25 (1–29) versus 7.5 (0–27.7), P = 0.015. In the original trial, neither survival nor PCPC demonstrated differences in all 3 subgroups—survival was greater with BVM for child maltreatment and respiratory arrest and favorable PCPC was greater with BVM for foreign body aspiration. Overall, in the current study, patients with more ICU‐free days also had greater survival to hospital discharge and more favorable PCPC scores. CONCLUSIONS: This initial study of the association between ICU‐free days and patient outcomes during prehospital pediatric resuscitation appears to support the use of ICU‐free days as a clinical endpoint in this population. ICU‐free days may be more sensitive than either mortality or PCPC alone while capturing aspects of both measures.
format Online
Article
Text
id pubmed-8262607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82626072021-07-13 ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients Cho, Hanjin Wendelberger, Barbara Gausche‐Hill, Marianne Wang, Henry E Hansen, Matthew Bosson, Nichole Lewis, Roger J. J Am Coll Emerg Physicians Open Pediatrics BACKGROUND: Our objective was to assess the association between intensive care unit (ICU)‐free days and patient outcomes in pediatric prehospital care and to evaluate whether ICU‐free days is a more sensitive outcome measure for emergency medical services research in this population. METHODS: This study used data from a previous pediatric prehospital trial. The original study enrolled patients ≤12 years of age and compared bag‐valve‐mask‐ventilation (BVM) versus endotracheal intubation (ETI) during prehospital resuscitation. For the current study, we defined ICU‐free days as 30 minus the number of days in the ICU (range, 0–30 days) and assigned 0 ICU‐free days for death within 30 days. We compared ICU‐free days between the original study treatment groups (BVM vs ETI) and with the original trial outcomes of survival to hospital discharge and Pediatric Cerebral Performance Category (PCPC). RESULTS: Median ICU‐free days for the BVM group (n = 404) versus ETI group (n = 416) was not statistically different: 0 ICU‐free days (interquartile range, 0–10) versus 0 (0–0), P = 0.219. Median ICU‐free days were greater for BVM group in 3 subgroups: foreign body aspiration 30 (0–30) versus 0 (0–21), P = 0.028; child maltreatment 0 (0–14.2) versus 0 (0‐0), P = 0.004; and respiratory arrest 25 (1–29) versus 7.5 (0–27.7), P = 0.015. In the original trial, neither survival nor PCPC demonstrated differences in all 3 subgroups—survival was greater with BVM for child maltreatment and respiratory arrest and favorable PCPC was greater with BVM for foreign body aspiration. Overall, in the current study, patients with more ICU‐free days also had greater survival to hospital discharge and more favorable PCPC scores. CONCLUSIONS: This initial study of the association between ICU‐free days and patient outcomes during prehospital pediatric resuscitation appears to support the use of ICU‐free days as a clinical endpoint in this population. ICU‐free days may be more sensitive than either mortality or PCPC alone while capturing aspects of both measures. John Wiley and Sons Inc. 2021-07-07 /pmc/articles/PMC8262607/ /pubmed/34263247 http://dx.doi.org/10.1002/emp2.12479 Text en © 2021 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of American College of Emergency Physicians https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Pediatrics
Cho, Hanjin
Wendelberger, Barbara
Gausche‐Hill, Marianne
Wang, Henry E
Hansen, Matthew
Bosson, Nichole
Lewis, Roger J.
ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients
title ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients
title_full ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients
title_fullStr ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients
title_full_unstemmed ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients
title_short ICU‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients
title_sort icu‐free days as a more sensitive primary outcome for clinical trials in critically ill pediatric patients
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262607/
https://www.ncbi.nlm.nih.gov/pubmed/34263247
http://dx.doi.org/10.1002/emp2.12479
work_keys_str_mv AT chohanjin icufreedaysasamoresensitiveprimaryoutcomeforclinicaltrialsincriticallyillpediatricpatients
AT wendelbergerbarbara icufreedaysasamoresensitiveprimaryoutcomeforclinicaltrialsincriticallyillpediatricpatients
AT gauschehillmarianne icufreedaysasamoresensitiveprimaryoutcomeforclinicaltrialsincriticallyillpediatricpatients
AT wanghenrye icufreedaysasamoresensitiveprimaryoutcomeforclinicaltrialsincriticallyillpediatricpatients
AT hansenmatthew icufreedaysasamoresensitiveprimaryoutcomeforclinicaltrialsincriticallyillpediatricpatients
AT bossonnichole icufreedaysasamoresensitiveprimaryoutcomeforclinicaltrialsincriticallyillpediatricpatients
AT lewisrogerj icufreedaysasamoresensitiveprimaryoutcomeforclinicaltrialsincriticallyillpediatricpatients